Article Details

Stopping IL-17 Drug for Axial Spondyloarthritis? Expect Spinal Flares

Retrieved on: 2021-05-11 15:56:15

Tags for this article:

Click the tags to see associated articles and topics

Stopping IL-17 Drug for Axial Spondyloarthritis? Expect Spinal Flares. View article details on hiswai:

Excerpt

Ixekizumab is a monoclonal antibody that targets interleukin (IL)-17A and has been approved for both radiographic and nonradiographic axial ...

Article found on: www.medpagetoday.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up